Baxter Bros Inc’s Pfizer PFE Stock Holding History

Baxter Bros Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Sell	54,137 -300	-0.6%	-$7.99K	0.19%	77
2025 Q4	$1.36M	Hold	54,437	–	–	0.16%	78
2025 Q3	$1.39M	Sell	54,437 -1,151	-2%	-$28.4K	0.16%	78
2025 Q2	$1.35M	Sell	55,588 -3,957	-7%	-$92.3K	0.16%	74
2025 Q1	$1.51M	Sell	59,545 -2,965	-5%	-$77.6K	0.2%	70
2024 Q4	$1.66M	Sell	62,510 -1,409	-2%	-$38.2K	0.22%	71
2024 Q3	$1.85M	Sell	63,919 -756	-1%	-$22.1K	0.24%	68
2024 Q2	$1.81M	Sell	64,675 -1,081	-2%	-$29.8K	0.24%	68
2024 Q1	$1.82M	Sell	65,756 -372	-0.6%	-$10.3K	0.23%	67
2023 Q4	$1.9M	Sell	66,128 -12,215	-16%	-$369K	0.26%	66
2023 Q3	$2.6M	Sell	78,343 -3,625	-4%	-$128K	0.39%	53
2023 Q2	$3.01M	Buy	81,968 +1,278	+2%	+$49.7K	0.45%	51
2023 Q1	$3.29M	Buy	80,690 +3,185	+4%	+$138K	0.52%	47
2022 Q4	$3.97M	Sell	77,505 -439	-0.6%	-$21K	0.65%	41
2022 Q3	$3.41M	Buy	77,944 +47,584	+157%	+$2.31M	0.6%	46
2022 Q2	$1.59M	Buy	30,360 +309	+1%	+$15.7K	0.29%	62
2022 Q1	$1.56M	Sell	30,051 -1,064	-3%	-$55.2K	0.23%	64
2021 Q4	$1.84M	Sell	31,115 -104	-0.3%	-$5.15K	0.27%	60
2021 Q3	$1.34M	Buy	31,219 +711	+2%	+$31.5K	0.22%	67
2021 Q2	$1.2M	Buy	30,508 +5,173	+20%	+$201K	0.19%	66
2021 Q1	$918K	Buy	25,335 +2,788	+12%	+$99K	0.16%	71
2020 Q4	$830K	Buy	22,547 +1,924	+9%	+$70.6K	0.16%	72
2020 Q3	$718K	Buy	20,623 +2,226	+12%	+$78K	0.16%	72
2020 Q2	$571K	Buy	18,397 +89	+0.5%	+$3.02K	0.13%	75
2020 Q1	$567K	Buy	18,308 +44	+0.2%	+$1.5K	0.15%	76
2019 Q4	$679K	Buy	18,264 +10	+0.1%	+$356	0.14%	79
2019 Q3	$622K	Buy	18,254 +115	+0.6%	+$4.18K	0.14%	75
2019 Q2	$746K	Sell	18,139 -523	-3%	-$20.8K	0.17%	72
2019 Q1	$752K	Sell	18,662 -34	-0.2%	-$1.36K	0.18%	74
2018 Q4	$774K	Buy	18,696 +2,462	+15%	+$102K	0.21%	69
2018 Q3	$679K	Sell	16,234 -1,640	-9%	-$63.1K	0.16%	77
2018 Q2	$615K	Sell	17,874 -5,213	-23%	-$178K	0.17%	77
2018 Q1	$777K	Buy	23,087 +8,807	+62%	+$303K	0.21%	74
2017 Q4	$491K	Sell	14,280 -11,810	-45%	-$403K	0.13%	84
2017 Q3	$884K	Buy	26,090 +7	+0%	+$225	0.25%	65
2017 Q2	$831K	Buy	26,083 +6	+0%	+$189	0.25%	66
2017 Q1	$846K	Buy	26,077 +3,750	+17%	+$118K	0.26%	64
2016 Q4	$688K	Buy	22,327 +470	+2%	+$14.3K	0.22%	68
2016 Q3	$702K	Buy	21,857 +7	+0%	+$234	0.24%	68
2016 Q2	$730K	Buy	+21,850	New	+$697K	0.26%	66
2015 Q4	$715K	Buy	23,355 +48	+0.2%	+$1.51K	0.26%	70
2015 Q3	$741K	Hold	23,307	–	–	0.27%	68
2015 Q2	$741K	Buy	23,307 +1,305	+6%	+$42.5K	0.27%	68
2015 Q1	$726K	Buy	22,002 +724	+3%	+$23K	0.26%	66
2014 Q4	$629K	Buy	21,278 +368	+2%	+$10.6K	0.23%	69
2014 Q3	$587K	Buy	20,910 +2,546	+14%	+$71.5K	0.23%	67
2014 Q2	$517K	Buy	18,364 +3	+0%	+$86	0.21%	71
2014 Q1	$560K	Buy	18,361 +2	+0%	+$60	0.25%	62
2013 Q4	$534K	Sell	18,359 -699	-4%	-$20.3K	0.25%	60
2013 Q3	$519K	Buy	+19,058	New	+$519K	0.28%	57

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Baxter Bros Inc's PFE Position: Q1 2026 in Review

Baxter Bros Inc reduced its Pfizer (PFE) stake by 0.55% in Q1 2026, selling an estimated $7.99K and leaving 54,137 shares worth $1.52M. The position accounts for 0.19% of the portfolio, ranked #77.

Baxter Bros Inc first reported a position in PFE in Q3 2013 and has held it in 50 quarters since. The position peaked at $3.97M in Q4 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Baxter Bros Inc held 54,137 shares of Pfizer worth $1.52M as of Q1 2026.
Baxter Bros Inc sold 300 Pfizer shares in Q1 2026, an estimated $7.99K.
Pfizer made up 0.19% of Baxter Bros Inc's portfolio in Q1 2026, its #77 holding.
Baxter Bros Inc first reported a position in Pfizer in Q3 2013 and has held it in 50 quarters since.
Baxter Bros Inc's Pfizer position peaked at $3.97M in Q4 2022.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.